ArticleDermatologic therapy2022

Real-world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety.

Pravit Asawanonda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.